Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D96XNU
|
|||
| Drug Name |
3VM1001
|
|||
| Indication | Knee osteoarthritis [ICD-11: FA01; ICD-10: M15-M19, M47; ICD-9: 715] | Phase 1/2 | [1] | |
| Postherpetic neuralgia [ICD-11: 1E91.5; ICD-10: G53.0; ICD-9: 53.19] | Phase 1/2 | [2] | ||
| Company |
CDA Research Group
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03142178) 3VM for Treatment of Chronic Osteoarthritis Knee Pain. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.